The literature review indicates distinct correlations between higher brain function impairments and specific DRP1 protein domains: encephalopathy and developmental regression were commonly observed in patients with pathogenic variants in the MD and GED domains, while peripheral neuropathy, ataxia, dystonia, and spasticity were more frequently associated with variants in the GTPase domain. This evidence concerns the gene DNM1L and peripheral neuropathy.